Forest Laboratories (NYSE:FRX) was downgraded by equities researchers at SunTrust from a “buy” rating to a “neutral” rating in a research report issued on Thursday, Analyst RN reports. Forest Laboratories, Inc. (NYSE:FRX) stock opened at $96.26 in last session, and closed at $98.25, while the day range of stock is $96.19 – $98.54. The stock showed a positive weekly performance of 37.62%.
Actavis plc Ordinary Shares (NYSE:ACT) will pay $89.48 per share, comprised of $26.04 in cash and 0.3306 of an Actavis share. The merger would create a company with combined forecast revenues of $15B in 2015 and free cash flow of over $4B. Actavis CEO Paul Bisaro will lead the new firm, while Forest CEO Brent will join Actavis’ board. In total, three Forest directors will gain seats on Activis’ board. Actavis plc Ordinary Shares (NYSE:ACT) stock opened at $217.75, in last session and closed at $222.37, by gaining 1.81%. The 52 week range of the stock is $82.44 – $223.65. Company’s market capitalization is $38.05 billion.
Agenus Inc. (NASDAQ:AGEN) was a big mover last session, as its shares rose nearly 7% on the day. The move came on solid volume too with far more shares changing hands than in a normal session. This continues the trend for the healthcare company since Feb 5, as the stock is now up almost 43%. Agenus Inc (NASDAQ:AGEN) stock advanced 8.51% and finished the last session at $4.21. The EPS of the stock remained -1.23. Company’s market capitalization is $229.71 million.
Novo Nordisk (NYSE:NVO) was upgraded by analysts at JPMorgan Chase & Co. to an “overweight” rating in a research report issued to clients and investors on Monday, Stock Ratings News reports. Novo Nordisk A/S (ADR) (NYSE:NVO) stock opened the session at $45.07, and closed the session at $45.82. The 52 week range of the stock remained $29.90 – $46.25 and the day range was $45.03 – $46.25.